Tunable, controlled-release, urethane-containing elastomers and processes of forming the same

A process forms an implantable product including poly(glycerol sebacate) urethane (PGSU) loaded with an active pharmaceutical ingredient (API). The process includes homogeneously mixing a flowable poly(glycerol sebacate) (PGS) resin with the API and a catalyst to form a resin blend. The process also...

Full description

Saved in:
Bibliographic Details
Main Authors Smoot, Carissa, D'Ottavio, John, Nicholson, Charles Brendan, Shull, Dennis, Gabriele, Peter D, Ely, Jared, Crumbling, Todd, Harris, Jeremy J, Reed, Stephanie
Format Patent
LanguageEnglish
Published 09.08.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A process forms an implantable product including poly(glycerol sebacate) urethane (PGSU) loaded with an active pharmaceutical ingredient (API). The process includes homogeneously mixing a flowable poly(glycerol sebacate) (PGS) resin with the API and a catalyst to form a resin blend. The process also includes homogeneously combining the resin blend with an isocyanate to form a reaction mixture and injecting the reaction mixture to form the PGSU loaded with the API. An implantable product includes a PGSU loaded with an API. In some embodiments, the implantable product includes at least 40% w/w of the API, and the implantable product releases the API by surface degradation of the PGSU at a predetermined release rate for at least three months under physiological conditions. In some embodiments, the PGSU is formed from a PGS reacted with an isocyanate at an isocyanate-to-hydroxyl stoichiometric (crosslinking) ratio in the range of 1:0.25 to 1:1.25.
Bibliography:Application Number: US202117148130